A Skin Testing Strategy for Non–IgE-Mediated Reactions Associated With Vancomycin
Year: 2024
Type: article
Study design: Observational Study
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: American Academy of Allergy Asthma and Immunology, AstraZeneca, Regeneron Pharmaceuticals, BioCryst, National Institutes of Health, National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Advancing Translational Sciences
Awards: Functional Characterization of Prostaglandin D2 in Chronic Spontaneous Urticaria, Regulation of Syk Expression in Human Basophils, G1991070941, Institutional Career Development Core, Stevens-Johnson syndrome/toxic epidermal necrolysis 2021: Collaboration, Innovation and Community, Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors, Using BTK Inhibitors to Prevent Anaphylactic Drug Reactions, Immune Tolerance Network, Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study), NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
OpenAlex ID: W4401371249